Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia-Reference-Cited by-同舟云学术

Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia

Published:2021-08-16 Issue:11 Volume:23 Page:2572-2581
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Goldenberg Ronald M.¹^ORCID,Aroda Vanita R.²^ORCID,Billings Liana K.³,Christiansen A. Sia Louise⁴,Meller Donatsky Anders⁵,Parvaresh Rizi Ehsan⁶,Podgorski Gracjan⁷,Raslova Katarina⁸,Klonoff David C.⁹^ORCID,Bergenstal Richard M.¹⁰

Affiliation:

1. LMC Diabetes and Endocrinology Concord Ontario Canada

2. Diabetes Clinical Research, Division of Endocrinology, Diabetes & Hypertension Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

3. Department of Medicine NorthShore University HealthSystem/University of Chicago Pritzker School of Medicine Skokie Illinois USA

4. Biostatistics, Insulin & Devices Novo Nordisk Søborg Denmark

5. Medical & Science, New Generation Insulins Novo Nordisk Søborg Denmark

6. Global Medical Affairs Novo Nordisk Søborg Denmark

7. Internal Medicine, Greenacres Hospital Port Elizabeth South Africa

8. Metabolic Center Ltd Bratislava Slovakia

9. Diabetes Research Institute Mills‐Peninsula Medical Center San Mateo CA USA

10. International Diabetes Center and HealthPartners Institute Minneapolis MN USA

Funder

Novo Nordisk

Publisher

Wiley